Glenmoore, PA, United States of America

Eliot Ohlstein

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 2.5

ph-index = 6

Forward Citations = 83(Granted Patents)


Location History:

  • Glenmore, PA (US) (2018 - 2020)
  • Glenmoore, PA (US) (2014 - 2021)

Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Eliot Ohlstein: Innovator in Pharmaceutical Solutions

Introduction

Eliot Ohlstein is a notable inventor based in Glenmoore, PA (US), recognized for his contributions to pharmaceutical innovations. With a total of 11 patents, Ohlstein has made significant strides in the field of medicine, particularly in treatments related to muscle strength and urinary tract symptoms.

Latest Patents

Among his latest patents is the invention titled "Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb." This invention provides methods for mitigating muscle loss by administering a specific compound, which is crucial for patients with immobilized limbs. Another significant patent is "Compositions and methods of using modified release solabegron for lower urinary tract symptoms." This application focuses on pharmaceutical compositions that utilize solabegron to treat conditions such as overactive bladder and prostate disorders, showcasing Ohlstein's commitment to improving patient care through innovative drug delivery systems.

Career Highlights

Eliot Ohlstein has worked with several prominent companies in the pharmaceutical industry, including Velicept Therapeutics, Inc. and VTV Therapeutics LLC. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical treatments.

Collaborations

Ohlstein has collaborated with notable professionals in his field, including Stephen Caltabiano and Stewart McCallum. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Eliot Ohlstein's work exemplifies the impact of innovation in the pharmaceutical industry. His patents reflect a dedication to addressing critical health issues, and his collaborations further strengthen his contributions to medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…